UK: Living Happily Ever After With Diabetes

Last Updated: 29 November 2016
Article by Mina Hinsch

November 14th was World Diabetes Day.i Today in the UK there are some 3.5 million people diagnosed with diabetes and 549,000 people living, unknowingly, with the condition. In 2015, diabetes cost the NHS some £10 billion, however, the real cost to the individual is the debilitating effect of the disease and the increased risk of developing life-threatening complications. People with diabetes are twice as likely to be admitted to hospital and, every day in the UK, some 65 people die prematurely from complications of diabetes. Improving the management of diabetes has significant implications for patient outcomes and reducing healthcare costs.ii This week's blog is a personal story of living with diabetes type 1 and the impact that health technology can have on improving diabetics' lives.

Earlier this summer I went shopping for a wedding dress with my best friend. What a special moment. Between lace, colour, and style, the most important selection criteria for my friend was:

"Will it accommodate my insulin pump and where will I place my continuous blood glucose sensor"?

Diabetes is a condition where the levels of glucose in the body become too high because the pancreas fails to produce any, or inadequate levels of, insulin. There are two types of the diabetes:

  • Type 1 diabetes, a life-long condition affecting about 10 per cent of diabetes patients. It occurs as a result of the destruction of insulin-producing cells and, following diagnosis, is treated by daily insulin doses, either by injections or via an insulin pump. It usually develops before the age of 40, and most commonly in childhood.
  • Type 2 diabetes, usually occurs in people over the age of 40. It is also becoming increasingly common in children and adolescents. It occurs when insulin-producing cells fail to produce enough insulin or the insulin produced is inadequate. It accounts for between 85 and 95 per cent of diabetics and is closely linked to life-style factors. If diagnosed early enough, it can be managed by losing weight, a healthy diet and increasing physical activity. Otherwise, treatment involves oral medication and eventually direct injection of insulin.iii

The inexorable increase in diabetes prevalence is largely due to the increase in type 2 diabetes. However, understanding what it means to live with life-long, type 1 diabetes can provide lessons and an incentive for better managing the 'slow epidemic' of preventable type 2 diabetes.

My friend was diagnosed with type 1 diabetes when we were teenagers in Germany. Our close friendship over the intervening years has given me the opportunity to see first-hand the impact diabetes can have but also share in the increased freedom that new technological developments have granted her. This includes travelling, a passion for rock-climbing and pursuing a career as a gynaecologist. Improvements in technology have also enabled my friend to reduce her risk of complications by optimising her average blood sugar levels.

From the outset, my friend's management of her diabetes involved the use of an insulin pump, allowing her to match the administration of long- and short-acting insulin to her lifestyle- rather than constraining her life to fixed daily insulin injections. Previously this would have required her to prick her fingers several times a day to self-monitor her blood sugar, while leaving gaps in monitoring that she called 'flying blind'. More recently, she has been able to avoid both by using a continuous blood glucose sensor which allows seamless monitoring and has resulted in improved management of her condition.

While she values the sensor highly, she had initially faced challenges obtaining funding for the device from her insurance company. She enjoys the flexibility of using an app on her phone for measuring and recording her blood sugar, however she does worry about data security and privacy. Meanwhile, her sights are set on upscaling to an 'artificial pancreas' system. This close-loop system consists of a sensor capable of continuously monitoring glucose levels and integrating with an insulin pump that autonomously calculates and administers the necessary treatment.iv

Unfortunately, many people living with diabetes today don't have access to these life-changing technologies. This is due to regulatory, cost and funding challenges, underpinned by a lack of understanding of the disease and limited awareness of technological developments, compounded by a reluctance among patients and staff to adopt new technology.

For others to enjoy the benefits that my friend now enjoys and at the same time alleviate some of the demand pressures on healthcare services, our UK health system needs to take the following steps.

Improving awareness of diabetes and its risks

Globally, as many as one in two of all patients with diabetes are undiagnosed (an estimated 193 million). Awareness campaigns and use of online questionnaires can help overcome the lack of knowledge about causes and risks of the disease.v On-line education and patient activation programmes can improve prevention, increase early diagnosis and reduce complications.vi

Enhancing early diagnosis and monitoring

New non-invasive screening to predict diabetes risks can speed up access to care. They also improve long-term management, enable tailored treatment and reduce the risk of life-threatening complications. One such tool uses visible light to assess skin biomarkers, whilst another uses tear drop or salivary assessments.vii These new technologies have yet to be widely adopted, rather, the focus has been on low cost, easy use diagnostic tools.viii

Reducing reluctance among patients and clinicians to engage with new technologies

Providing patients and clinicians with information on the growing evidence of the efficiency and effectiveness of digital technology and improving their education on its use, is a crucial first step to gaining trust and confidence. On-line learning, for example, can increase knowledge of treatment options and improve clinical and psychosocial outcomes.ix Evidence from the X-PERT Diabetes programme has demonstrated savings to the NHS, of some £367 million per year.x

Tackling accessibility and equality of access within the UK

To harness the full potential of technology, financial and regulatory barriers need to be addressed. Currently not all patients with type 1 diabetes are offered insulin pump therapy and fewer still are able to obtain continuous glucose monitoring, and then only after individual funding requests. NICE guidance in February 2016 concluded that routine adoption is not yet supported by sufficient evidence.xi

Diabetes is currently a chronic condition and there is as yet no cure. However, equitable access to technology is an important enabler for improving the monitoring and compliance of treatment while reducing healthcare costs and improving the quality of life for millions of people.

For my friend, it certainly makes all the difference. She did find a beautiful wedding dress. It was a marvellous day and the stains on the dress, were not the result of having to prick her finger repeatedly throughout the day, but rather told the story of a fabulous party.

Footnotes

https://www.diabetes.org.uk/Get_involved/World-Diabetes-Day/

ii   https://www.diabetes.org.uk/Documents/Position%20statements/Diabetes%20UK%20Facts%20and%20Stats_Dec%202015.pdf

iii  https://www.diabetes.org.uk/Guide-to-diabetes/What-is-diabetes/

iv  https://www.diabetes.org.uk/Research/Research-round-up/First-artificial-pancreas-approved-for-use-in-the-United-States/

http://riskscore.diabetes.org.uk/start

vi   https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/primary-care-today-and-tomorrow.html

vii  http://www.forbes.com/sites/reenitadas/2016/11/14/how-technology-will-change-diabetes-management/#4795ffb62eeb

viii  https://www.engineeringforchange.org/eight-tools-and-one-idea-for-ultra-low-cost-diabetes-screening/

ix  https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/connected-health.html

http://selfmanagementuk.org/programmes

xi https://www.nice.org.uk/guidance/DG21/chapter/1-Recommendations 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.